Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Highly AccessReview

Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine

Lance D Miller email and Edison T Liu email

Genome Institute of Singapore, 60 Biopolis Street, #02-01, Singapore 138672

author email corresponding author email

Breast Cancer Research 2007, 9:206doi:10.1186/bcr1662

Published: 26 March 2007

Abstract

Genome-wide expression microarray studies have revealed that the biological and clinical heterogeneity of breast cancer can be partly explained by information embedded within a complex but ordered transcriptional architecture. Comprising this architecture are gene expression networks, or signatures, reflecting biochemical and behavioral properties of tumors that might be harnessed to improve disease subtyping, patient prognosis and prediction of therapeutic response. Emerging 'hypothesis-driven' strategies that incorporate knowledge of pathways and other biological phenomena in the signature discovery process are linking prognosis and therapy prediction with transcriptional readouts of tumorigenic mechanisms that better inform therapeutic options.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.